A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01).

Autor: Hirota, Yushi1 (AUTHOR), Kakei, Yasumasa2 (AUTHOR), Imai, Junta3 (AUTHOR), Katagiri, Hideki3 (AUTHOR), Ebihara, Ken4 (AUTHOR), Wada, Jun5 (AUTHOR), Suzuki, Junichi6 (AUTHOR), Urakami, Tatsuhiko6 (AUTHOR), Omori, Takashi7 (AUTHOR), Ogawa, Wataru1 (AUTHOR) ogawa@med.kobe-u.ac.jp
Zdroj: Diabetes Therapy. Feb2024, Vol. 15 Issue 2, p533-545. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje